NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Wednesday 27 February 2008

Evonik plans IPO and sale

Further to reports earlier this week about the future of Evonik, RAG-Stiftung reportedly plans to sell 25% of Evonik to a financial investor, float 50% in an IPO and retain 25%. RAG plans to approach Permira, BC Partners, KKR, Bain Capital and Blackstone. David Blitzer, senior managing director at Blackstone, said Blackstone may be interested in acquiring a stake in Evonik.
Forbes
Hemscott

No comments: